Panlong Pharmaceutical: Net profit in 2025 was 96.2794 million yuan, a year-on-year decrease of 19.95%.

Panlong Pharmaceutical announced that its operating income in 2025 was 1.141 billion yuan, an increase of 17.15% year-on-year. The net profit was 96.2794 million yuan, a decrease of 19.95% year-on-year. The profit distribution plan approved by the board of directors is based on a total of 106 million yuan, distributing a cash dividend of 2.5 yuan for every 10 shares to all shareholders, with no bonus shares, and allocating 3 shares for every 10 shares from the capital reserve to all shareholders.